(Q88976382)

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

7

Marcin Drag

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

author name string

Wioletta Rut

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

Katarzyna Groborz

2

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

Linlin Zhang

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

Xinyuanyuan Sun

4

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

27 May 2020

Mikolaj Zmudzinski

5

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

A distinct name is needed for the new coronavirus

27 May 2020

language of work or name

English

0 references

publication date

9 March 2020

0 references

published in

bioRxiv

0 references

cites work

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes.

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Small Molecule Active Site Directed Tools for Studying Human Caspases

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Applications of Unnatural Amino Acids in Protease Probes

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Expedient solid-phase synthesis of fluorogenic protease substrates using the 7-amino-4-carbamoylmethylcoumarin (ACC) fluorophore.

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

XDSAPP: a graphical user interface for the convenient processing of diffraction data usingXDS

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Scaling and assessment of data quality

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

An introduction to data reduction: space-group determination, scaling and intensity statistics

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Overview of the CCP4 suite and current developments

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Molecular replacement with MOLREP

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

JLigand: a graphical tool for the CCP4 template-restraint library

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

Features and development of Coot

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

REFMAC5 for the refinement of macromolecular crystal structures

12 April 2021

1 reference

https://api.crossref.org/works/10.1101/2020.03.07.981928

12 April 2021

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.03.07.981928

Dimensions Publication ID

27 May 2020

1125488690

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

10.6084/M9.FIGSHARE.11961063